Cellweaverse Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $4.33M

  • Investors
  • 11

Cellweaverse General Information

Description

Developer of cell culture-based biomaterials designed for the production of animal-derived materials without animal harvesting. The company's platform utilizes proprietary cell line development and cultivation technologies to produce biomaterials for biomedical, pharmaceutical, cosmetic, food, and industrial applications, including endotoxin testing materials and alternative biological raw materials, enabling biotechnology, healthcare, and manufacturing organizations to access animal-derived biomaterials through controlled cell-based production methods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, 87 Cheongam-ro
  • Room 638-7, Nam-gu, Jigok-dong, Changeup Ground
  • Pohang, Gyeonggi-do
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Corporate Office
  • 6th Floor, 87 Cheongam-ro
  • Room 638-7, Nam-gu, Jigok-dong, Changeup Ground
  • Pohang, Gyeonggi-do
  • South Korea
+82

Cellweaverse Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellweaverse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 09-Sep-2026 $4.33M Completed Generating Revenue
4. Accelerator/Incubator 22-Dec-2025 Completed Generating Revenue
3. Accelerator/Incubator 07-Apr-2025 Completed Generating Revenue
2. Accelerator/Incubator 01-Nov-2024 Completed Generating Revenue
1. Seed Round 01-Nov-2024 Completed Generating Revenue
To view Cellweaverse’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellweaverse Patents

Cellweaverse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026054241-A1 Deodorant composition for removing senile odor comprising magnoliae flos extract or fraction Pending 03-Sep-2024

Cellweaverse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellweaverse Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
CKD Venture Capital Corporate Venture Capital Minority
Industrial Bank of Korea PE/Buyout Minority
Korea Technology Finance Government Minority
Mirae Asset Venture Investment Venture Capital Minority
Posco Investment Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Cellweaverse FAQs

  • When was Cellweaverse founded?

    Cellweaverse was founded in 2024.

  • Where is Cellweaverse headquartered?

    Cellweaverse is headquartered in Pohang, South Korea.

  • What is the size of Cellweaverse?

    Cellweaverse has 9 total employees.

  • What industry is Cellweaverse in?

    Cellweaverse’s primary industry is Biotechnology.

  • Is Cellweaverse a private or public company?

    Cellweaverse is a Private company.

  • What is Cellweaverse’s current revenue?

    The current revenue for Cellweaverse is .

  • How much funding has Cellweaverse raised over time?

    Cellweaverse has raised $4.33M.

  • Who are Cellweaverse’s investors?

    CKD Venture Capital, Industrial Bank of Korea, Korea Technology Finance, Mirae Asset Venture Investment, and Posco Investment are 5 of 11 investors who have invested in Cellweaverse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process